Verition Fund Management LLC Purchases 25,440 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Verition Fund Management LLC grew its position in The Cooper Companies, Inc. (NASDAQ:COO) by 153.1% in the third quarter, HoldingsChannel.com reports. The fund owned 42,053 shares of the medical device company’s stock after buying an additional 25,440 shares during the period. Verition Fund Management LLC’s holdings in Cooper Companies were worth $4,640,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently modified their holdings of COO. LRI Investments LLC boosted its holdings in shares of Cooper Companies by 4.5% during the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock worth $227,000 after buying an additional 112 shares during the period. Mitchell & Pahl Private Wealth LLC boosted its holdings in shares of Cooper Companies by 1.5% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock worth $881,000 after buying an additional 117 shares during the period. Commonwealth Equity Services LLC boosted its holdings in shares of Cooper Companies by 0.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock worth $1,362,000 after buying an additional 118 shares during the period. Bleakley Financial Group LLC boosted its holdings in shares of Cooper Companies by 2.1% during the 3rd quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock worth $636,000 after buying an additional 119 shares during the period. Finally, First Horizon Advisors Inc. boosted its holdings in shares of Cooper Companies by 4.8% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after buying an additional 125 shares during the period. Institutional investors own 24.39% of the company’s stock.

Insider Buying and Selling

In related news, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares in the company, valued at $700,422.60. This represents a 78.94 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. This represents a 41.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 141,381 shares of company stock worth $15,508,071 in the last three months. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $103.29 on Wednesday. The firm has a 50 day moving average of $105.04 and a 200-day moving average of $98.66. The stock has a market capitalization of $20.57 billion, a PE ratio of 57.54, a PEG ratio of 2.23 and a beta of 0.97. The Cooper Companies, Inc. has a 12 month low of $82.55 and a 12 month high of $112.38. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Wall Street Analysts Forecast Growth

COO has been the subject of several research analyst reports. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Robert W. Baird lifted their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. StockNews.com upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Tuesday. Piper Sandler lifted their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Finally, Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.